Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Mass spectrometry confirms molecular weight matching expected values
TB-500 brings its own strengths
Research has examined multiple administration routes with varying levels of success
Although the incidence of adverse events (AEs) between bimagrumab and placebo was similar, there was a transient increase in pancreatic and liver enzyme levels observed with the use of bimagrumab [97]
PMID: 14647006
US$ 20.85
US$ 25.85
US$ 25.76
US$ 22.75
US$ 27.15
US$ 26.09
US$ 27.66
